Atika Capital Management »

Immunome shares owned by Atika Capital Management

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.8M 315k 24.68

More positions owned by Atika Capital Management

EXACT Sciences Corporation Call Option (EXAS)
Ishares Tr Rus Top 200 Etf Call Option (IWL)
NVIDIA Corporation (NVDA)
Shockwave Med
Microsoft Corporation (MSFT)
Vertiv Holdings Com Cl A (VRT)
Inspire Med Sys (INSP)
Amazon (AMZN)
MercadoLibre (MELI)
Eli Lilly & Co. (LLY)
Intuitive Surgical Com New (ISRG)
Rxsight (RXST)
Meta Platforms Cl A (META)
Sentinelone Cl A (S)
Appfolio Com Cl A (APPF)

View all positions for Atika Capital Management

Top funds holding Immunome

T. Rowe Price Investment Management
Redmile Group
BlackRock
EcoR1 Capital
BlackRock
Henderson Group
Vanguard Group
State Street Corporation
T. Rowe Price Associates
Marshall Wace
Opaleye Management
Geode Capital Management
Woodline Partners
Avidity Partners Management
Victory Capital Management

View all funds holding Immunome